The number of anti-vaccine bills filed in Texas has risen, yet many Texans support vaccine policy. Fellow Kirstin R.W. Matthews and nonresident scholar Rekha Lakshmanan examine the stakes of legislative engagement in public health initiatives and provide a call to action for Texans to embrace public health as an act of freedom.
Fellow Harris Eyre calls for strategic investments in R&D and the application of brain-related technologies to harness the full potential of our minds.
Considering the dangers of advanced AI and AI-enhanced social media, there is an urgent need to design neuroscience-based policies to support citizens in building a system of digital self-defense. Enter the “Neuroshield.”
Drug companies that bypass distributors and offer generics directly to patients, like the Mark Cuban Cost Plus Drug Company, could disrupt the pharmaceutical supply chain and ultimately save thousands of lives.
"Creating a global norm for PPA transparency is a zero-cost step to help provide energy for everyone and deliver on the low carbon future we all need," write the authors. Read their post about power purchase agreements on the Baker Institute Blog.
This article originally appeared in the Forbes blog on June 1, 2022.
"This is a moment to prioritise health over short-term political calculations," write fellow Peter Hotez, Rekha Lakshmanan and nine other experts in a Lancet commentary. Click here for their call for action against anti-vaccine rhetoric and COVID-19 misinformation, and five short-term recommendations.
Rekha Lakshmanan, Peter J. HotezSeptember 17, 2021
Texans served by regulated electricity markets, especially by electric cooperatives, were much more satisfied with their providers’ performance during Winter Storm Uri than those in deregulated markets. In this post for the Baker Institute Blog, the authors offer possible explanations for the contrast in favorability.
Mark P. Jones, Pablo M. Pinto, Renee Cross, Kirk P. WatsonMay 11, 2021
